This study evaluates the efficacy of Acu‐URO17, a highly sensitive and specific immunocytochemistry (ICC) test targeting Keratin 17, in comparison to urine cytology and UroVysionTM fluorescence in situ hybridization (FISH) for detecting bladder cancer cells in voided urine specimens. The gene discussed is KRT17; the disease is urinary bladder cancer.